<qa>  What is the STUDY OF THE SAFETY OF SUBCUTANEOUSLYA STUDY OF THE SAFETY OF SUBCUTANEOUSLY ADMINISTERED TRASTUZUMAB HERCEPTIN IN PARTICIPANTS WITH EARLY AND LOCALLY ADVANCED HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 HER2-POSITIVE BREAST CANCER: 